Brooks Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Brooks Laboratories has informed the exchanges that its trading window will be closed for designated persons and their immediate relatives starting April 1, 2026, in line with SEBI's Prohibition of Insider Trading Regulations. The window will remain shut until 48 hours after the company declares its audited financial results (both standalone and consolidated) for the quarter and full year ended March 31, 2026. This is a standard compliance measure that prevents insiders from trading in the company's shares while they may be in possession of unpublished financial information. The exact date of the board meeting to approve the results will be communicated later.
This is a routine regulatory filing and is not expected to impact the stock price directly. However, it signals that the company's Q4 and FY26 audited results are likely to be announced within the next few weeks, which investors should watch for as it could drive the next significant price movement.